Literature DB >> 15677659

Recent developments in atrial fibrillation.

M Bilal Iqbal1, Anil K Taneja, Gregory Y H Lip, Marcus Flather.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15677659      PMCID： PMC546076          DOI： 10.1136/bmj.330.7485.238

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  27 in total

Review 1.  Antithrombotic therapy in atrial fibrillation.

Authors:  G W Albers; J E Dalen; A Laupacis; W J Manning; P Petersen; D E Singer
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse
Journal:  Eur Heart J       Date:  2001-10       Impact factor: 29.983

3.  Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter.

Authors:  I C Van Gelder; H J Crijns; W H Van Gilst; R Verwer; K I Lie
Journal:  Am J Cardiol       Date:  1991-07-01       Impact factor: 2.778

4.  Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group.

Authors:  D G Benditt; J H Williams; J Jin; T F Deering; R Zucker; K Browne; P Chang-Sing; B N Singh
Journal:  Am J Cardiol       Date:  1999-08-01       Impact factor: 2.778

5.  Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation.

Authors:  C F Tsai; C T Tai; M H Hsieh; W S Lin; W C Yu; K C Ueng; Y A Ding; M S Chang; S A Chen
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

6.  Incidence of chronic atrial fibrillation in general practice and its treatment pattern.

Authors:  Ana Ruigómez; Saga Johansson; Mari Ann Wallander; Luis Alberto García Rodríguez
Journal:  J Clin Epidemiol       Date:  2002-04       Impact factor: 6.437

7.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

8.  Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.

Authors: 
Journal:  J Am Coll Cardiol       Date:  2003-07-02       Impact factor: 24.094

9.  Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm.

Authors:  A Borgeat; J J Goy; R Maendly; U Kaufmann; M Grbic; U Sigwart
Journal:  Am J Cardiol       Date:  1986-09-01       Impact factor: 2.778

10.  Epidemiologic features of chronic atrial fibrillation: the Framingham study.

Authors:  W B Kannel; R D Abbott; D D Savage; P M McNamara
Journal:  N Engl J Med       Date:  1982-04-29       Impact factor: 91.245
View more
  11 in total

Review 1.  Antithrombotic treatment in atrial fibrillation.

Authors:  G Y H Lip; C J Boos
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

2.  One hundred years of atrial fibrillation.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2005-10       Impact factor: 4.335

Review 3.  Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis.

Authors:  Kwok M Ho; David J Sheridan; Timothy Paterson
Journal:  Heart       Date:  2007-04-20       Impact factor: 5.994

Review 4.  [Anticoagulation for stroke prevention. An update].

Authors:  H C Koennecke
Journal:  Nervenarzt       Date:  2007-10       Impact factor: 1.214

5.  Benefits and risks of long-term amiodarone therapy for persistent atrial fibrillation: a meta-analysis.

Authors:  James F Doyle; Kwok M Ho
Journal:  Mayo Clin Proc       Date:  2009-03       Impact factor: 7.616

6.  Value of trans-oesophageal echocardiography as a method of encouraging patients with chronic atrial fibrillation to use anticoagulation therapy.

Authors:  A Bakalli; L Kamberi; G Dragusha; N Zeqiri; F Gashi; L Prekpalaj
Journal:  Cardiovasc J Afr       Date:  2010 Jul-Aug       Impact factor: 1.167

Review 7.  Sleep Duration and Risk of Atrial Fibrillation: a Systematic Review.

Authors:  Negar Morovatdar; Negar Ebrahimi; Ramin Rezaee; Hoorak Poorzand; Mohammad Amin Bayat Tork; Amirhossein Sahebkar
Journal:  J Atr Fibrillation       Date:  2019-04-30

Review 8.  Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies.

Authors:  Neil S Roskell; Miny Samuel; Herbert Noack; Brigitta U Monz
Journal:  Europace       Date:  2013-02-13       Impact factor: 5.214

9.  The use of antithrombotics in patients presenting with stroke and atrial fibrillation.

Authors:  Carl Burgess; Tristram Ingham; Martin Woodbridge; Mark Weatherall; Michael Nowitz
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

10.  The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling.

Authors:  Li-Juan Liu; Feng-Juan Yao; Gui-Hua Lu; Cheng-Gui Xu; Zhe Xu; Kai Tang; Yun-Jiu Cheng; Xiu-Ren Gao; Su-Hua Wu
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.